VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-00117
Package ID: USCOURTS-cofc-1_16-vv-00117
Petitioner: John Barczuk
Filed: 2016-01-27
Decided: 2018-02-28
Vaccine: influenza
Vaccination date: 2013-01-16
Condition: Parsonage Turner Syndrome
Outcome: compensated
Award amount USD: 10000

AI-assisted case summary:
John Barczuk filed a petition for compensation under the National Vaccine Injury Compensation Program on January 27, 2016. He alleged that he suffered Parsonage Turner Syndrome (PTS) caused by his January 16, 2013 influenza vaccination. Mr. Barczuk further alleged that he experienced residual effects of this injury for more than six months and confirmed that there had been no prior award or settlement of a civil action for damages as a result of his condition. The respondent denied that the influenza vaccine caused the petitioner's alleged PTS or any other injury or his current condition. Despite the respondent's denial, the parties filed a joint stipulation for compensation on November 15, 2017. Chief Special Master Nora Beth Dorsey reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. Pursuant to the stipulation, Mr. Barczuk was awarded $10,000.00 as a lump sum, payable by check to the petitioner, as compensation for all items of damages available under the Vaccine Act. The decision was issued on February 28, 2018. Petitioner was represented by Diana Lynn Stadelnikas of Maglio Christopher & Toale, PA, and respondent was represented by Robert Paul Coleman, III, of the U.S. Department of Justice.

Theory of causation field:
Petitioner John Barczuk alleged that his January 16, 2013 influenza vaccination caused Parsonage Turner Syndrome (PTS), with residual effects lasting more than six months. The respondent denied causation. The parties filed a joint stipulation for compensation, which was approved by Chief Special Master Nora Beth Dorsey on February 28, 2018. The stipulation resulted in a $10,000.00 lump sum award to the petitioner. The specific medical mechanism, expert testimony, or detailed clinical facts supporting the theory of causation were not described in the provided public decision text, as the case was resolved via stipulation.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-00117-0
Date issued/filed: 2018-02-28
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 11/15/2017) regarding 44 DECISION Stipulation/Proffer. Signed by Chief Special Master Nora Beth Dorsey. (rp) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-117V
Filed: November 15, 2017
UNPUBLISHED
JOHN BARCZUK,
Special Processing Unit (SPU); Joint
Stipulation on Damages; Influenza
Petitioner,
(Flu) Vaccine; Parsonage Turner
v.
Syndrome
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Diana Lynn Stadelnikas, Maglio Christopher & Toale, PA, Sarasota, FL, for petitioner.
Robert Paul Coleman, III, U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Dorsey, Chief Special Master:
On January 27, 2016, petitioner filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered Parsonage Turner Syndrome (“PTS”)
caused by his January 16, 2013 influenza (“flu”) vaccination. Petition at 1; Stipulation,
filed November 15, 2017, at ¶ 4. Petitioner further alleges he experienced residual
effects of this injury for more than six months and that there has been no prior award or
settlement of a civil action for damages as a result of his condition. Petition at 2;
Stipulation at ¶¶ 4-5. “Respondent denies that the influenza vaccine is the cause of
petitioner’s alleged PTS, and/or any other injury or his current condition. ” Stipulation at
¶ 6.
Nevertheless, on November 15, 2017, the parties filed the attached joint
stipulation, stating that a decision should be entered awarding compensation. The
1 Because this unpublished decision contains a reasoned explanation for the action in this case, the
undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would constitute an
unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits
within this definition, the undersigned will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 2 of 7
undersigned finds the stipulation reasonable and adopts it as the decision of the Court
in awarding damages, on the terms set forth therein.
Pursuant to the terms stated in the attached Stipulation, the undersigned
awards the following compensation:
A lump sum of $10,000.00 in the form of a check payable to petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of
damages that would be available under 42 U.S.C. § 300aa-15(a). Id.
The undersigned approves the requested amount for petitioner’s compensation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court is directed to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 3 of 7

Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 4 of 7

Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 5 of 7

Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 6 of 7

Case 1:16-vv-00117-UNJ Document 49 Filed 02/28/18 Page 7 of 7